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Commentary: Methodological reasons for not gaining prior
informed consent are sometimes justified
Angus J Dawson
Informed consent is generally required before medical
research interventions.1–3 Despite this, good reasons
not to seek such consent often exist. Examples might
include research with incompetent patients, research
using anonymised tissue samples, and certain types of
epidemiological research.4 Another reason, often
forgotten, is where there are methodological reasons
not to seek consent in advance of the intervention.
Boter et al’s study represents such an occasion.1
Informed consent could not be given before the
research as the methodology involved the patients
assessing their own quality of life. Requiring prior con-
sent would have led to potentially biased results.5
Is this study unethical because informed consent
was not gained in advance? Leaving aside the fact that
the research could not have been accomplished if such
consent were required, such a claim raises an
important ethical issue. Arguably, no ethical principle
should be absolute in this way. Situations are complex,
andminor changes canmake a significant difference to
the way that we assess them. Different ethical and
methodological issues need to be weighed against each
other and a defensible judgment made on the basis of
all of the relevant factors.
In this case, the procedure for consenting was ethi-
cally justified because the study considers an important
issue; the results could be achieved with blinding to the
issue to be investigated; and any possible harm to the
participants was negligible.
Even if we agree that the alternative of not doing the
study would have treated the patients with more respect,6
it is not clear it would have been more ethical, as the
results of the study will improve the quality of life of
stroke victims.5 Blindly applying absolute principles such
as “always gain prior informed consent” does not guaran-
tee ethical outcomes. Such an approach might well be
harmful, as potentially beneficial studies will not be done.
One concern about the study’s approach might be
that it still places too much emphasis upon consent.7
Informing the participants in advance that some infor-
mation about the research was withheld could have
caused anxiety. As a result, participants might have
imagined themselves in all sorts of distressing
scenarios. An alternative would have been to say noth-
ing about the consent issue until after the study was
completed. It is not clear that the “modified” informed
consent procedure is preferable. However, it is impor-
tant that this research found that most participants
could, retrospectively, appreciate the methodological
reasons for not seeking prior consent, and they gener-
ally seemed happy to be involved in such research.
Researchers, journals, and the members of
research ethics committees should all take note of
these findings and should be more willing to weigh up
the appropriateness of seeking prior informed consent
given the methodology employed in a study. An abso-
lute requirement to gain always an informed consent
may do more harm than good.
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Comparison of reporting of ethnicity in US and European
randomised controlled trials
Aziz Sheikh, Gopalakrishnan Netuveli, Joe Kai, Sukhmeet Singh Panesar
Increasing evidence shows that different ethnic groups
respond differently to educational, psychosocial, and
pharmacological interventions. If diverse communities
are to benefit from the implementation of appropri-
ately derived evidence then it is imperative that the
ethnic diversity of populations under study are
reflected in clinical trials. In the United States, since
1993, the National Institutes of Health have instituted
policy insisting that minority groups are represented in
study samples unless there is a compelling reason not
to do so.1 However, no comparable legislation exists in
Europe. We sought to compare reporting of ethnicity
in published reports of US and European randomised
controlled studies.
Methods and results
We searched Medline for reports of trials published in
2002 using the Cochrane optimal search strategy.2 We
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downloaded titles and abstracts of study reports into
the reference manager database and randomly
selected 200 reports for further scrutiny. We identified
trials done in the United States and Europe and got full
text reports. We assessed any description of the ethnic-
ity of participants in detail. We used a broad definition
of ethnicity that included any reference to race, ethnic
origin, language, or nationality. We categorised studies
as either detailing the ethnicity of subjects or not. Two
reviewers independently extracted data on to a
prepiloted sheet; they resolved disagreements through
discussion.
We used descriptive statistics to find the proportion
of studies reporting information on the ethnicity of
subjects and used the 2 test to compare reporting of
ethnicity in United States and European published
reports.
For 80% power at the 5% significance level
(two tailed test) of detecting a difference from 20% to
40% in the proportion of studies reporting on ethnic-
ity, assuming that one in five European trials detailed
this information, we needed to identify a total of 182
trials.
Our searches retrieved 12 683 titles and abstracts,
from which we selected 200 for further scrutiny. Of
these, 154 studies satisfied our inclusion criteria
(figure). A total of 59 (38%) of these trials were based
in the United States and 95 (62%) in Europe. Overall,
30 (19%) reports included information on the ethnic
profile of participants. American studies were
significantly more likely to report on ethnicity
than European studies (23 v 7; 39% v 7%; relative
risk 5.3, 95% confidence interval 2.4 to 11.6;
P < 0.0001).
Comment
American studies are five times more likely than Euro-
pean trials to report information on the ethnicity of
participants. The random selection procedures
adopted and the standardised and independent
extraction of data with an initially agreed approach to
handle disagreements should have minimised the risk
of selection bias or information bias accounting for
these findings.
Our results seem likely to reflect active policies in
the United States. For example, all federally supported
programmes with sufficient sample size are required
to report statistics according to race or ethnicity.3
None the less, it is still concerning that only two fifths
of recently published trials from the United States
report on the ethnicity of participants. Possible expla-
nations include known difficulties in identifying,
enrolling, and following up minority ethnic popula-
tions in trials. Another possible factor is the argument
that ethnicity reporting is only important in specific
disease areas with known ethnic disparities. Relevant
here are recent data showing that in the study of such
conditions 59% of US trials report on the ethnicity of
participants.4
Mechanisms to facilitate inclusion and standards to
ensure reporting of minority ethnic communities in
studies are needed. These reporting standards are
absent in current CONSORT requirements and we
suggest that the merits of insisting on presentation of
such data, where appropriate, should be debated.5 In
particular, European governments should consider the
US model for promoting inclusion of ethnic minority
participants in research.
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Misunderstood
Said the little boy, “Sometimes I drop my spoon.”
Said the old man, “I do that too.”
The little boy whispered, “I wet my pants.”
“I do that too,” laughed the old man.
Said the little boy, “I often cry.”
The old man nodded, “So do I.”
“But worst of all,” said the little boy, “it seems
grown-ups don’t pay attention to me.” And he felt
the warmth of a wrinkled old hand.
“I know what you mean,” said the little old man.
Silverstein S. The little boy and the old man.
In: A light in the attic. New York: Harper Collins, 1981
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